Furthermore, we have also established a significant association between FEV downregulation and shorter BCR-free PCa patient survival in both our cohort as well as in the TCGA dataset, thereby prompting us to elucidate the contribution of FEV to malignant phenotypes of PCa in vitro systems and in vivo models. The gene discussed is FEV; the disease is posterior cortical atrophy.